Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 41 citing articles:

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 68
Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
Yuru Chen, Jiazheng Sun, Yachan Luo, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Hyperprogression of cutaneous T cell lymphoma after anti–PD-1 treatment
Yumei Gao, Simeng Hu, Ruoyan Li, et al.
JCI Insight (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 18
Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020
Małgorzata Bobrowicz, Christina Fassnacht, Desislava Ignatova, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 10, pp. 733-745
Open Access | Times Cited: 42
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 584-584
Open Access | Times Cited: 4
Unveiling the Role of the Cellular Tumor Microenvironment and the Therapeutic Targets it Provides in Cutaneous T-Cell Lymphoma
Nikolaos A. Chinas, Stella Kaliampou, Vasiliki Nikolaou
Current Oncology Reports (2025)
Open Access
Engineered PD-L1 co-expression in PD-1 knockout and MAGE-C2-targeting TCR-T cells augments the cytotoxic efficacy toward target cancer cells
Fangxin Zhao, Xuan Zhang, Ying Tang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Phase II Trial of Atezolizumab (Anti-PD-L1) in the Treatment of Relapsed/Refractory IIB/IVB Mycosis Fungoides / Sézary Syndrome Patients after Previous Systemic Treatment. EORTC-1652-CLTG “PARCT”
Rudolf Stadler, Gabriele Roccuzzo, Pablo L. Ortiz‐Romero, et al.
European Journal of Cancer (2025), pp. 115484-115484
Open Access
The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication
Joseph S. Durgin, David M. Weiner, Maria Wysocka, et al.
Journal of the American Academy of Dermatology (2020) Vol. 84, Iss. 3, pp. 587-595
Open Access | Times Cited: 27
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
Gabriele Roccuzzo, Silvia Giordano, Paolo Fava, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 21
Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
Ari Pelcovits, Thomas Ollila, Adam J. Olszewski
Cancer Management and Research (2023) Vol. Volume 15, pp. 989-998
Open Access | Times Cited: 7
The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells
Guranda Chitadze, Ulrike Wehkamp, Ottmar Janßen, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5947-5947
Open Access | Times Cited: 17
Mycosis fungoides and Sézary syndrome
Constanze Jonak, Julia Tittes, Patrick M. Brunner, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2021) Vol. 19, Iss. 9, pp. 1307-1334
Open Access | Times Cited: 16
Integrating novel agents into the treatment of advanced mycosis fungoides and Sézary syndrome
Michael S. Khodadoust, Eric Mou, Youn H. Kim
Blood (2022) Vol. 141, Iss. 7, pp. 695-703
Open Access | Times Cited: 11
The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome
Denis Miyashiro, Bruno de Castro e Souza, Marina Passos Torrealba, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 936-936
Open Access | Times Cited: 10
Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma
Yi-Chien Tsai, Tanja Schlaepfer, Desislava Ignatova, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 5, pp. 603-611
Open Access | Times Cited: 6
Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions
Yun‐Tsan Chang, Desislava Ignatova, Wolfram Hoetzenecker, et al.
JID Innovations (2021) Vol. 2, Iss. 1, pp. 100069-100069
Open Access | Times Cited: 13
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome
Natasha Lewis, Qi Gao, Kseniya Petrova‐Drus, et al.
Cytometry Part B Clinical Cytometry (2022) Vol. 102, Iss. 3, pp. 189-198
Open Access | Times Cited: 9
Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma
Amy Xiao, Oleg E. Akilov
Cells (2022) Vol. 11, Iss. 22, pp. 3591-3591
Open Access | Times Cited: 8
Single-cell RNA-sequencing reveals predictive features of response to pembrolizumab in Sézary syndrome
Tianying Su, George E. Durán, Alexa Kwang, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients
Susanne Melchers, M. Roemer, John D. Albrecht, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 9
Open Access | Times Cited: 1
The Tumor Microenvironment as a Therapeutic Target in Cutaneous T Cell Lymphoma
Louis Boafo Kwantwi, Steven T. Rosen, Christiane Querfeld
Cancers (2024) Vol. 16, Iss. 19, pp. 3368-3368
Open Access | Times Cited: 1
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome
Christoph Iselin, Yun‐Tsan Chang, Tanja Schlaepfer, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 9
mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma
Marina Tusup, Severin Läuchli, Natalia Teresa Jarzębska, et al.
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 1040-1040
Open Access | Times Cited: 8
Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas
Megan E. Gumina, Madeline Hooper, Xiaolong Zhou, et al.
Journal of Investigative Dermatology (2023) Vol. 144, Iss. 4, pp. 755-763
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top